Agilent Technologies(A)
Search documents
Agilent to Participate in TD Cowen Health Care Conference
Businesswire· 2024-02-07 16:20
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that CFO Bob McMahon will participate in a fireside chat at the 44th Annual TD Cowen Health Care Conference in Boston, Massachusetts, on Monday, March 4, at 2:50 p.m. EST. A live audio webcast and replay of the presentation will be available on the Agilent Investor Relations website. About Agilent Technologies Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, ...
Agilent Technologies (A) Stock Slides as Market Rises: Facts to Know Before You Trade
Zacks Investment Research· 2024-02-03 00:16
The most recent trading session ended with Agilent Technologies (A) standing at $132.97, reflecting a -0.06% shift from the previouse trading day's closing. The stock fell short of the S&P 500, which registered a gain of 1.07% for the day. Elsewhere, the Dow gained 0.35%, while the tech-heavy Nasdaq added 1.74%.The the stock of scientific instrument maker has risen by 1.56% in the past month, lagging the Computer and Technology sector's gain of 4.83% and the S&P 500's gain of 2.93%.Market participants will ...
FTV vs. A: Which Stock Is the Better Value Option?
Zacks Investment Research· 2024-02-01 17:46
Investors with an interest in Electronics - Testing Equipment stocks have likely encountered both Fortive (FTV) and Agilent Technologies (A) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The Zacks Rank favors stocks with str ...
Agilent Announces Collaboration with Incyte to Develop Advanced Companion Diagnostics in Hematology and Oncology
Businesswire· 2024-01-30 13:00
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced an agreement with Incyte that will bring together Agilent’s expertise and proven track record in the development of companion diagnostics (CDx) to support the development and commercialization of Incyte’s hematology and oncology portfolio. The value of the companion diagnostics market is predicted to expand to nearly US $14B by 2030,1 driven in part by the power of these tests to inform treatment decisions for a gro ...
Agilent Technologies (A) Advances While Market Declines: Some Information for Investors
Zacks Investment Research· 2024-01-27 00:21
The latest trading session saw Agilent Technologies (A) ending at $130.99, denoting a +0.85% adjustment from its last day's close. The stock outpaced the S&P 500's daily loss of 0.07%. On the other hand, the Dow registered a gain of 0.16%, and the technology-centric Nasdaq decreased by 0.36%.Heading into today, shares of the scientific instrument maker had lost 7.08% over the past month, lagging the Computer and Technology sector's gain of 5.93% and the S&P 500's gain of 3.05% in that time.Analysts and inve ...
Agilent to Announce First-Quarter Fiscal Year 2024 Financial Results Feb. 27
Businesswire· 2024-01-25 17:29
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will release financial results for the first quarter of fiscal year 2024 after the stock market closes on Tuesday, Feb. 27. In addition, the company will host a conference call to discuss the results at 1:30 p.m. PST. To join the listen-only conference call webcast, click the link on the Events section of Agilent’s investor relations website. A recording of the call will also be available on the website for 90 days. About Agilent Te ...
The 3 Most Promising Picks in Manufacturing Stocks for 2024
InvestorPlace· 2024-01-22 20:35
Over the past 80 years, the United States faced a persistent issue of in-state manufacturing decline, marked by a shift towards research and development rather than domestic production. The trend led to a significant loss of manufacturing jobs, peaking in the 2000s with a 33% decrease. However, technology is now reshaping U.S. manufacturing, offering a modern and advanced system. Investing in this upward trend, with an expected 5.2% rise in wages and benefits, can usher in a prosperous new era for American ...
Agilent (A) Boosts DGG Segment With ProteoAnalyzer System
Zacks Investment Research· 2024-01-17 19:01
To boost capabilities in protein analysis, Agilent Technologies (A) announced the launch of the Agilent ProteoAnalyzer system.The Agilent ProteoAnalyzer system is a new automated parallel capillary electrophoresis system for protein analysis that brings more efficiency, versatility and reliability in protein QC workflows by automating the separation, data processing and simplifying sample preparation steps.This way, it analyzes complex protein mixtures seamlessly.It is designed to analyze different sizes an ...
FTV vs. A: Which Stock Should Value Investors Buy Now?
Zacks Investment Research· 2024-01-16 17:47
Investors looking for stocks in the Electronics - Testing Equipment sector might want to consider either Fortive (FTV) or Agilent Technologies (A) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The Zacks Rank favors stocks wi ...
U.S. Wide-Moat Stocks On Sale - The January 2024 Heat Map
Seeking Alpha· 2024-01-10 18:17
ValeryEgorov Step one: Wide-moat stocks with 5-star and 4-star ratings Historical evidence says that while quality alone is a poor indicator of outperformance, when combined with a decent valuation filter, Morningstar’s moat rating proves to be more than useful. Based on the available data, stocks with a wide-moat rating that also fit into the 4- or 5-star category deserve to be the subject of further analysis. See the detailed explanation and the underlying evidence of our first step in this article. W ...